From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
Become a hepatitis B s100 prescriber to manage and treat chronic hepatitis B in primary care settings.
9.5 CPD hours
No upcoming sessions that suit you? Express your interest to be notified if a course is planned in your area.
This course provides Medical Practitioners and Nurse Practitioners with comprehensive training in the science of hepatitis B virus (HBV), current pharmacology, monitoring and treatment, and the complicating factors surrounding HBV management. Through case discussions and facilitated group work, attendees will have an opportunity to discuss practical strategies with peers and specialists.
Upon successful completion of this training and the associated case assessment, eligible participants may apply to the relevant state departments of health for authority to prescribe Section 100 (s100) drugs for the management of HBV in Australia.
On completion of this course, participants will be able to:
This is an approved activity under the RACGP CPD Program (7.5 Educational Activities hours, 2 Reviewing Performance hours).
This event has been accredited in the 2026-2028 ACRRM CPD Program (7.5 Educational Activity Hours, 2 Performance Review hours).
This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for 9.5 CPD hours.
All participants who attend the course in full will be awarded a Statement of Attendance.
Please note you will receive separate statements of attendance for the online learning modules and facilitated training.
General Practitioners, Nurse Practitioners, other community based medical practitioners based in Australia.
Australian STI Management Guidelines For Use In Primary Care: Trans and Gender Diverse People
The Decision Making in Gender Affirming Contraception: Consultation Essentials resource is a valuable tool designed to support clinicians to conduct gender affirming contraceptive consultations. Based on ASHM’s Decision Making in Contraception Tool this quick reference resource addresses the specific contraceptive needs of trans and gender diverse people, particularly those on hormone therapy.
The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis.
In this 90-minute case discussion, participants will discuss a range of hepatitis B case studies with a specialist or experienced hepatitis B s100 prescriber, highlighting approaches to diagnosing, treating and managing people living with hepatitis B.
Supporting Clients with Legal Issues: Practical Skills for the BBV Healthcare Workforce, E-learning is designed to empower clinicians and health workers to identify common legal issues experienced by people living with blood-borne viruses (BBVs) and connect them with appropriate legal services. This E-learning was developed in partnership with Health + Law.
Become a HIV s100 prescriber to manage and treat HIV in primary care settings.
Are you passionate about educating other healthcare professionals on your area of expertise?
Express your interest in speaking at future ASHM courses
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM